1 of 5
FEATURED COMPANIES
- Baxter International Inc
- Eli Lilly and Company
- Injex
- Novo Nordisk A/S
- Sanofi Sa
- Terumo Corporation
- MORE
MARKET OUTLOOK
According to an analysis by the publisher, the global injectable drug delivery market is predicted to show growth at 8.66% of CAGR in the forecasting period between 2019 and 2028.
Factors such as technological advancements, growth in the geriatric population, and the rise in cases of autoimmune diseases are majorly driving the market for injectable drug delivery. In addition, the formulation of better injectable systems and the rise in healthcare spending are likely to open up new avenues for market growth. This growth, however, is being restrained by the high manufacturing costs of these drug delivery systems. Also, the advent of alternate drug delivery systems and stringent regulations to govern the usage of these systems are acting as hurdles in the path of market growth.
REGIONAL OUTLOOK
The global market for injectable drug delivery spans across Europe, North America, Latin America, the Asia-Pacific, and the Middle East and Africa.
The Asia-Pacific is expected to become the fastest-growing market globally, over the coming period. There is a vast population of older adults in this region. In China, 15.02% of the population was aged 60 years and above in 2015. This percentage is rising rapidly, and is expected to reach 25.3% by 2030. Also, owing to advancements in medical science, the average life expectancy has increased. For instance, 33% of Japan’s population was 60 years or older in 2015. Old age makes one vulnerable to several diseases and health conditions, such as autoimmune diseases, diabetes, CVD, chronic pain, etc. thus, the increase in the number of older adults significantly increases the incidence of these conditions. The growing prevalence of these conditions is creating an enhanced demand for injectable drug delivery systems, which is helping the growth of the studied market in the region.
COMPETITIVE OUTLOOK
The top companies that have been studied in the injectable drug delivery market are Novo Nordisk A/S, Elcam Medical, Novartis AG, Sanofi SA, Schott AG, Injex, Ypsomed Holding AG, Eli Lilly and Company, Pfizer Inc, Terumo Corporation, Gerresheimer, West Pharmaceuticals, Teva Pharmaceuticals, Baxter International Inc, and Becton Dickinson and Company (BD).
Baxter International Inc is a leading company engaged in developing, manufacturing, and marketing hospital equipment for a range of disorders. Research laboratories form a major end-user segment of the company. The company manufactures products in 20 countries and has a strong distribution network offering its products in more than 100 countries. Baxter was founded in 1931, and now boasts of a strong workforce of 48,000 employees. In May 2020, it received regulatory approval for developing the Evo IQ Syringe Infusion System. With this approval, Baxter intends to strengthen its infusion systems portfolio.
According to an analysis by the publisher, the global injectable drug delivery market is predicted to show growth at 8.66% of CAGR in the forecasting period between 2019 and 2028.
Factors such as technological advancements, growth in the geriatric population, and the rise in cases of autoimmune diseases are majorly driving the market for injectable drug delivery. In addition, the formulation of better injectable systems and the rise in healthcare spending are likely to open up new avenues for market growth. This growth, however, is being restrained by the high manufacturing costs of these drug delivery systems. Also, the advent of alternate drug delivery systems and stringent regulations to govern the usage of these systems are acting as hurdles in the path of market growth.
REGIONAL OUTLOOK
The global market for injectable drug delivery spans across Europe, North America, Latin America, the Asia-Pacific, and the Middle East and Africa.
The Asia-Pacific is expected to become the fastest-growing market globally, over the coming period. There is a vast population of older adults in this region. In China, 15.02% of the population was aged 60 years and above in 2015. This percentage is rising rapidly, and is expected to reach 25.3% by 2030. Also, owing to advancements in medical science, the average life expectancy has increased. For instance, 33% of Japan’s population was 60 years or older in 2015. Old age makes one vulnerable to several diseases and health conditions, such as autoimmune diseases, diabetes, CVD, chronic pain, etc. thus, the increase in the number of older adults significantly increases the incidence of these conditions. The growing prevalence of these conditions is creating an enhanced demand for injectable drug delivery systems, which is helping the growth of the studied market in the region.
COMPETITIVE OUTLOOK
The top companies that have been studied in the injectable drug delivery market are Novo Nordisk A/S, Elcam Medical, Novartis AG, Sanofi SA, Schott AG, Injex, Ypsomed Holding AG, Eli Lilly and Company, Pfizer Inc, Terumo Corporation, Gerresheimer, West Pharmaceuticals, Teva Pharmaceuticals, Baxter International Inc, and Becton Dickinson and Company (BD).
Baxter International Inc is a leading company engaged in developing, manufacturing, and marketing hospital equipment for a range of disorders. Research laboratories form a major end-user segment of the company. The company manufactures products in 20 countries and has a strong distribution network offering its products in more than 100 countries. Baxter was founded in 1931, and now boasts of a strong workforce of 48,000 employees. In May 2020, it received regulatory approval for developing the Evo IQ Syringe Infusion System. With this approval, Baxter intends to strengthen its infusion systems portfolio.
Note: Product cover images may vary from those shown
2 of 5
FEATURED COMPANIES
- Baxter International Inc
- Eli Lilly and Company
- Injex
- Novo Nordisk A/S
- Sanofi Sa
- Terumo Corporation
- MORE
1. Global Injectable Drug Delivery Market - Summary
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrant
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Intensity of Competitive Rivalry
2.3. Patent Analysis
2.4. Key Insight
2.5. Key Buying Criteria
2.6. Legal Requirement
2.7. Regulatory Framework
2.8. Market Attractiveness Index
2.9. Market Drivers
2.9.1. Increasing Geriatric Population
2.9.2. Technological Advancement
2.9.3. Growing Occurrence of Autoimmune Diseases
2.10. Market Restraints
2.10.1. High Manufacturing Cost of Injectable Drug Delivery Systems
2.11. Market Opportunities
2.11.1. Development of Better Injectable Systems
2.11.2. Increase in Healthcare Expenditure
2.12. Market Challenges
2.12.1. Developments in Alternate Drug Delivery Systems
2.12.2. Stringent Regulations
3. Injectable Drug Delivery Market Outlook - by Device Type
3.1. Pen Injector
3.2. Auto‐Injector
3.3. Needle-Free Injector
3.3.1. Spring‐Based Needle‐Free Injector
3.3.2. Gas‐Based Needle‐Free Injector
3.3.3. Other Needle-Free Injector
3.4. Prefilled Syringe
3.4.1. Glass-Prefilled Syringe
3.4.2. Plastic-Prefilled Syringe
4. Injectable Drug Delivery Market Outlook - by Route of Administration
4.1. Subcutaneous
4.2. Intramuscular
4.3. Intravenous (Iv)
4.4. Other Route of Administration
5. Injectable Drug Delivery Market Outlook - by End-User
5.1. Clinics/ Physician Offices
5.2. Ambulatory Care
5.3. Hospital
5.4. Home-Based
5.5. Other End-Users
6. Injectable Drug Delivery Market – Regional Outlook
6.1. North America
6.1.1. Market by Device Type
6.1.2. Market by Route of Administration
6.1.3. Market by End-User
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Device Type
6.2.2. Market by Route of Administration
6.2.3. Market by End-User
6.2.4. Country Analysis
6.2.4.1. United Kingdom
6.2.4.2. Germany
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Spain
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Device Type
6.3.2. Market by Route of Administration
6.3.3. Market by End-User
6.3.4. Country Analysis
6.3.4.1. Japan
6.3.4.2. China
6.3.4.3. Australia & New Zealand
6.3.4.4. India
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Device Type
6.4.2. Market by Route of Administration
6.4.3. Market by End-User
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Device Type
6.5.2. Market by Route of Administration
6.5.3. Market by End-User
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. Turkey
6.5.4.3. United Arab Emirates
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa
7. Company Profiles
7.1. Baxter International Inc
7.2. Becton Dickinson and Company (Bd)
7.3. Elcam Medical
7.4. Eli Lilly and Company
7.5. Gerresheimer
7.6. Injex
7.7. Novartis AG
7.8. Novo Nordisk A/S
7.9. Pfizer Inc
7.10. Sanofi Sa
7.11. Schott AG
7.12. Terumo Corporation
7.13. Teva Pharmaceuticals
7.14. West Pharmaceuticals
7.15. Ypsomed Holding AG
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis
List of Tables
Table 1 Global Injectable Drug Delivery Market, by Region, 2019-2028 ($ Million)
Table 2 Global Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 3 Different Types of Insulin Pen Injectors
Table 4 Marketed Needle-Free Injectors Products
Table 5 Global Needle-Free Injector by Type, 2019-2028 ($ Million)
Table 6 Lyophilized Drugs Which Are Used in Prefilled Syringe
Table 7 Global Prefilled Syringe, by Type, 2019-2028 ($ Million)
Table 8 Global Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 9 Global Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 10 Global Injectable Drug Delivery Market, by Region, 2019-2028 ($ Million)
Table 11 North America Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 12 North America Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 13 North America Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 14 North America Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 15 Europe Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 16 Europe Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 17 Europe Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 18 Europe Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 19 Asia-Pacific Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 20 Asia-Pacific Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 21 Asia-Pacific Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 22 Asia-Pacific Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 23 Latin America Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 24 Latin America Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 25 Latin America Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 26 Latin America Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 27 Middle East and Africa Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 28 Middle East and Africa Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 29 Middle East and Africa Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 30 Middle East and Africa Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
List of Figures
Figure 1 Global Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 2 Key Buying Impact Analysis
Figure 3 Global Injectable Drug Delivery Market, by Pen Injector, 2019-2028 ($ Million)
Figure 4 Global Injectable Drug Delivery Market, by Auto‐Injector, 2019-2028 ($ Million)
Figure 5 Global Injectable Drug Delivery Market, by Needle-Free Injector, 2019-2028 ($ Million)
Figure 6 Global Needle-Free Injector Market, by Spring‐Based Needle‐Free Injector, 2019-2028 ($ Million)
Figure 7 Global Needle-Free Injector Market, by Gas‐Based Needle‐Free Injector, 2019-2028 ($ Million)
Figure 8 Global Needle-Free Injector Market, by Other Needle-Free Injector, 2019-2028 ($ Million)
Figure 9 Global Injectable Drug Delivery Market, by Prefilled, 2019-2028 ($ Million)
Figure 10 Global Prefilled Syringe Market, by Glass-Prefilled Syringe, 2019-2028 ($ Million)
Figure 11 Global Prefilled Syringes Market, by Plastic-Prefilled Syringe, 2019-2028 ($ Million)
Figure 12 Global Injectable Drug Delivery Market, by Subcutaneous, 2019-2028 ($ Million)
Figure 13 Global Injectable Drug Delivery Market, by Intramuscular, 2019-2028 ($ Million)
Figure 14 Global Injectable Drug Delivery Market, by Intravenous, 2019-2028 ($ Million)
Figure 15 Global Injectable Drug Delivery Market, by Other Route of Administration, 2019-2028 ($ Million)
Figure 16 Global Injectable Drug Delivery Market, by Clinics/Physician Offices, 2019-2028 ($ Million)
Figure 17 Global Injectable Drug Delivery Market, by Ambulatory Care, 2019-2028 ($ Million)
Figure 18 Global Injectable Drug Delivery Market, by Hospital, 2019-2028 ($ Million)
Figure 19 Global Injectable Drug Delivery Market, by Home-Based, 2019-2028 ($ Million)
Figure 20 Global Injectable Drug Delivery Market, by Other End-User, 2019-2028 ($ Million)
Figure 21 United States Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 22 Canada Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 23 United Kingdom Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 24 Germany Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 25 France Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 26 Italy Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 27 Spain Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 28 Russia Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 29 Rest of Europe Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 30 Japan Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 31 China Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 32 Australia & New Zealand Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 33 India Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 34 South Korea Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 35 Asean Countries Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 36 Rest of Asia-Pacific Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 37 Brazil Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 38 Mexico Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 39 Rest of Latin America Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 40 Saudi Arabia Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 41 Turkey Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 42 United Arab Emirates Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 43 South Africa Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 44 Rest of Middle East & Africa Injectable Drug Delivery Market 2019-2028 ($ Million)
2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Model
2.2.1. Threat of New Entrant
2.2.2. Threat of Substitute
2.2.3. Bargaining Power of Buyers
2.2.4. Bargaining Power of Suppliers
2.2.5. Intensity of Competitive Rivalry
2.3. Patent Analysis
2.4. Key Insight
2.5. Key Buying Criteria
2.6. Legal Requirement
2.7. Regulatory Framework
2.8. Market Attractiveness Index
2.9. Market Drivers
2.9.1. Increasing Geriatric Population
2.9.2. Technological Advancement
2.9.3. Growing Occurrence of Autoimmune Diseases
2.10. Market Restraints
2.10.1. High Manufacturing Cost of Injectable Drug Delivery Systems
2.11. Market Opportunities
2.11.1. Development of Better Injectable Systems
2.11.2. Increase in Healthcare Expenditure
2.12. Market Challenges
2.12.1. Developments in Alternate Drug Delivery Systems
2.12.2. Stringent Regulations
3. Injectable Drug Delivery Market Outlook - by Device Type
3.1. Pen Injector
3.2. Auto‐Injector
3.3. Needle-Free Injector
3.3.1. Spring‐Based Needle‐Free Injector
3.3.2. Gas‐Based Needle‐Free Injector
3.3.3. Other Needle-Free Injector
3.4. Prefilled Syringe
3.4.1. Glass-Prefilled Syringe
3.4.2. Plastic-Prefilled Syringe
4. Injectable Drug Delivery Market Outlook - by Route of Administration
4.1. Subcutaneous
4.2. Intramuscular
4.3. Intravenous (Iv)
4.4. Other Route of Administration
5. Injectable Drug Delivery Market Outlook - by End-User
5.1. Clinics/ Physician Offices
5.2. Ambulatory Care
5.3. Hospital
5.4. Home-Based
5.5. Other End-Users
6. Injectable Drug Delivery Market – Regional Outlook
6.1. North America
6.1.1. Market by Device Type
6.1.2. Market by Route of Administration
6.1.3. Market by End-User
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Device Type
6.2.2. Market by Route of Administration
6.2.3. Market by End-User
6.2.4. Country Analysis
6.2.4.1. United Kingdom
6.2.4.2. Germany
6.2.4.3. France
6.2.4.4. Italy
6.2.4.5. Spain
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Device Type
6.3.2. Market by Route of Administration
6.3.3. Market by End-User
6.3.4. Country Analysis
6.3.4.1. Japan
6.3.4.2. China
6.3.4.3. Australia & New Zealand
6.3.4.4. India
6.3.4.5. South Korea
6.3.4.6. Asean Countries
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Device Type
6.4.2. Market by Route of Administration
6.4.3. Market by End-User
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Device Type
6.5.2. Market by Route of Administration
6.5.3. Market by End-User
6.5.4. Country Analysis
6.5.4.1. Saudi Arabia
6.5.4.2. Turkey
6.5.4.3. United Arab Emirates
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa
7. Company Profiles
7.1. Baxter International Inc
7.2. Becton Dickinson and Company (Bd)
7.3. Elcam Medical
7.4. Eli Lilly and Company
7.5. Gerresheimer
7.6. Injex
7.7. Novartis AG
7.8. Novo Nordisk A/S
7.9. Pfizer Inc
7.10. Sanofi Sa
7.11. Schott AG
7.12. Terumo Corporation
7.13. Teva Pharmaceuticals
7.14. West Pharmaceuticals
7.15. Ypsomed Holding AG
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives of Study
8.1.2. Scope of Study
8.2. Sources of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation of Proposed Market
8.3.2. Identification of Data Sources
8.3.3. Assessment of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis
List of Tables
Table 1 Global Injectable Drug Delivery Market, by Region, 2019-2028 ($ Million)
Table 2 Global Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 3 Different Types of Insulin Pen Injectors
Table 4 Marketed Needle-Free Injectors Products
Table 5 Global Needle-Free Injector by Type, 2019-2028 ($ Million)
Table 6 Lyophilized Drugs Which Are Used in Prefilled Syringe
Table 7 Global Prefilled Syringe, by Type, 2019-2028 ($ Million)
Table 8 Global Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 9 Global Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 10 Global Injectable Drug Delivery Market, by Region, 2019-2028 ($ Million)
Table 11 North America Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 12 North America Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 13 North America Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 14 North America Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 15 Europe Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 16 Europe Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 17 Europe Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 18 Europe Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 19 Asia-Pacific Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 20 Asia-Pacific Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 21 Asia-Pacific Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 22 Asia-Pacific Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 23 Latin America Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 24 Latin America Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 25 Latin America Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 26 Latin America Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
Table 27 Middle East and Africa Injectable Drug Delivery Market, by Device Type, 2019-2028 ($ Million)
Table 28 Middle East and Africa Injectable Drug Delivery Market, by Route of Administration, 2019-2028 ($ Million)
Table 29 Middle East and Africa Injectable Drug Delivery Market, by End-User, 2019-2028 ($ Million)
Table 30 Middle East and Africa Injectable Drug Delivery Market, by Country, 2019-2028 ($ Million)
List of Figures
Figure 1 Global Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 2 Key Buying Impact Analysis
Figure 3 Global Injectable Drug Delivery Market, by Pen Injector, 2019-2028 ($ Million)
Figure 4 Global Injectable Drug Delivery Market, by Auto‐Injector, 2019-2028 ($ Million)
Figure 5 Global Injectable Drug Delivery Market, by Needle-Free Injector, 2019-2028 ($ Million)
Figure 6 Global Needle-Free Injector Market, by Spring‐Based Needle‐Free Injector, 2019-2028 ($ Million)
Figure 7 Global Needle-Free Injector Market, by Gas‐Based Needle‐Free Injector, 2019-2028 ($ Million)
Figure 8 Global Needle-Free Injector Market, by Other Needle-Free Injector, 2019-2028 ($ Million)
Figure 9 Global Injectable Drug Delivery Market, by Prefilled, 2019-2028 ($ Million)
Figure 10 Global Prefilled Syringe Market, by Glass-Prefilled Syringe, 2019-2028 ($ Million)
Figure 11 Global Prefilled Syringes Market, by Plastic-Prefilled Syringe, 2019-2028 ($ Million)
Figure 12 Global Injectable Drug Delivery Market, by Subcutaneous, 2019-2028 ($ Million)
Figure 13 Global Injectable Drug Delivery Market, by Intramuscular, 2019-2028 ($ Million)
Figure 14 Global Injectable Drug Delivery Market, by Intravenous, 2019-2028 ($ Million)
Figure 15 Global Injectable Drug Delivery Market, by Other Route of Administration, 2019-2028 ($ Million)
Figure 16 Global Injectable Drug Delivery Market, by Clinics/Physician Offices, 2019-2028 ($ Million)
Figure 17 Global Injectable Drug Delivery Market, by Ambulatory Care, 2019-2028 ($ Million)
Figure 18 Global Injectable Drug Delivery Market, by Hospital, 2019-2028 ($ Million)
Figure 19 Global Injectable Drug Delivery Market, by Home-Based, 2019-2028 ($ Million)
Figure 20 Global Injectable Drug Delivery Market, by Other End-User, 2019-2028 ($ Million)
Figure 21 United States Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 22 Canada Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 23 United Kingdom Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 24 Germany Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 25 France Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 26 Italy Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 27 Spain Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 28 Russia Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 29 Rest of Europe Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 30 Japan Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 31 China Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 32 Australia & New Zealand Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 33 India Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 34 South Korea Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 35 Asean Countries Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 36 Rest of Asia-Pacific Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 37 Brazil Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 38 Mexico Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 39 Rest of Latin America Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 40 Saudi Arabia Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 41 Turkey Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 42 United Arab Emirates Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 43 South Africa Injectable Drug Delivery Market 2019-2028 ($ Million)
Figure 44 Rest of Middle East & Africa Injectable Drug Delivery Market 2019-2028 ($ Million)
Note: Product cover images may vary from those shown
3 of 5
LOADING...
4 of 5
- Baxter International Inc
- Becton Dickinson and Company (Bd)
- Elcam Medical
- Eli Lilly and Company
- Gerresheimer
- Injex
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc
- Sanofi Sa
- Schott AG
- Terumo Corporation
- Teva Pharmaceuticals
- West Pharmaceuticals
- Ypsomed Holding AG
Note: Product cover images may vary from those shown
5 of 5
LOADING...
